16-11553578-G-C
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PM2PM5PP5_Very_Strong
The NM_001136472.2(LITAF):c.332C>G(p.Ala111Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A111T) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001136472.2 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease type 1CInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- Charcot-Marie-Tooth diseaseInheritance: AD Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 1C Pathogenic:2Other:1
Variant summary: LITAF c.332C>G (p.Ala111Gly) results in a non-conservative amino acid change located in the LPS-induced tumour necrosis factor alpha factor domain (IPR006629) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251206 control chromosomes. c.332C>G has been reported in the literature in multiple individuals affected with Charcot-Marie Disease Type 1C and segregated with disease in at least one family (e.g. Latour_2006). These data indicate that the variant is very likely to be associated with disease. Experimental in vitro studies show that this variant causes mislocalization (e.g. Zhu_2013, Lacerda_2014). The following publications have been ascertained in the context of this evaluation (PMID: 25058650, 16787513, 23576546). ClinVar contains an entry for this variant (Variation ID: 41229). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects LITAF function (PMID: 23576546, 25058650). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 41229). This missense change has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 16787513, 32376792). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 111 of the LITAF protein (p.Ala111Gly). -
Charcot-Marie-Tooth disease Pathogenic:1Uncertain:1
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at